Sun Pharmaceutical Industries Ltd., commonly known as Sun Pharma, is one of India's leading multinational pharmaceutical companies. It was founded in 1983 by Dilip Shanghvi in Vapi, Gujarat. Today, its headquarters are located in Mumbai, Maharashtra.

Sun Pharma is known for manufacturing and distributing a wide range of pharmaceutical products, including prescription drugs, over-the-counter medications, and active pharmaceutical ingredients (APIs). The company's product portfolio covers a variety of therapeutic areas, such as cardiology, neurology, psychiatry, dermatology, ophthalmology, and respiratory. Operating on a global scale, Sun Pharma has a presence in over 100 countries.

The company has established its presence through subsidiaries, joint ventures, and strategic partnerships. Some of its notable subsidiaries include Taro Pharmaceutical Industries Ltd., a leading global specialty pharmaceutical company based in the United States, and Ranbaxy Laboratories, an Indian pharmaceutical company that Sun Pharma acquired in 2015, making it the largest pharmaceutical company in India. In terms of market position, Sun Pharma is considered one of the largest and most influential pharmaceutical companies in India and globally.

It has consistently been ranked among the top generic drug manufacturers worldwide. The company's continuous focus on research and development, as well as its strong distribution network, has contributed to its market dominance. Over the years, Sun Pharma has achieved various milestones and received recognition for its contributions to the pharmaceutical industry.

It has received numerous awards for its manufacturing facilities and quality control practices. Additionally, the company has undergone several strategic changes, such as acquisitions and collaborations, to expand its product portfolio and market reach. As of the latest updates, Sun Pharma continues to strengthen its global presence and invest in research and development to launch new innovative products.

The company has been actively involved in the development and distribution of COVID-19 treatments, demonstrating its commitment to global health. Sun Pharma remains a key player in the pharmaceutical industry, constantly adapting to market demands and driving growth through its diverse product offerings and global operations